• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME COPORATION SYNVISC PFS; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME COPORATION SYNVISC PFS; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problems Renal Failure (2041); Urinary Tract Infection (2120); Obstruction/Occlusion (2422)
Event Type  Injury  
Event Description
Pt reported surgery for bowel obstruction, and had a uti.She was given vancomycin which caused acute kidney failure and put her back in the hosp requiring dialysis for a short.She states everything seems to be getting better now.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC PFS
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
GENZYME COPORATION
MDR Report Key17020031
MDR Text Key316221313
Report NumberMW5117958
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 05/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/26/2023
Patient Sequence Number1
Treatment
VANCOMYCIN
Patient Outcome(s) Hospitalization;
Patient SexFemale
-
-